Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Antimigraine agents with reduced liability for side effects developed at MS&D

Feb. 27, 1998

Orally active thrombin inhibitors prepared at C&C

Feb. 27, 1998

Merck describes newly discovered beta3-adrenoceptor agonists

Feb. 26, 1998

Cell adhesion inhibitors from Yoshitomi

Feb. 26, 1998

Agouron discloses new HIV protease inhibitors

Feb. 26, 1998

Muscarinic cholinergic agents from American Home

Feb. 24, 1998

SKB evaluates RF-1 as antibacterial target

Feb. 23, 1998

Pharmacia & Upjohn develops new antiproliferative agents

Feb. 23, 1998

Chloride channel blockers useful for sickle cell anemia

Feb. 23, 1998

Novel NK1 antagonists described by Merck & Co.

Feb. 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...